Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation.

Jain, Tania; Kosiorek, Heidi E; Grys, Thomas E; Kung, Shu Ting; Shah, Vishal S; Betcher, Jeffrey A; Slack, James L; Leis, Jose F; Khera, Nandita; Noel, Pierre; Palmer, Jeanne M; Sproat, Lisa Z

Jain, Tania; Kosiorek, Heidi E; Grys, Thomas E; Kung, Shu Ting; Shah, Vishal S; Betcher, Jeffrey A; Slack, James L; Leis, Jose F; Khera, Nandita; Noel, Pierre; Palmer, Jeanne M; Sproat, Lisa Z.

Affiliation

Jain T; a Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , AZ , USA.
Kosiorek HE; b Division of Biostatistics, Mayo Clinic , Scottsdale , AZ , USA.
Grys TE; c Department of Laboratory Medicine and Pathology , Mayo Clinic , Phoenix , AZ , USA.
Kung ST; d Department of Internal Medicine , Mayo Clinic , Phoenix , AZ , USA.
Shah VS; e Division of Pharmacy , Mayo Clinic , Phoenix , AZ , USA.
Betcher JA; e Division of Pharmacy , Mayo Clinic , Phoenix , AZ , USA.
Slack JL; a Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , AZ , USA.
Leis JF; a Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , AZ , USA.
Khera N; a Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , AZ , USA.
Noel P; a Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , AZ , USA.
Palmer JM; a Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , AZ , USA.
Sproat LZ; a Division of Hematology and Medical Oncology , Mayo Clinic , Phoenix , AZ , USA.

Leuk Lymphoma ; 60(1): 110-117, 2019 01.

Article in En | MEDLINE | ID: mdl-29979906

Subject(s)

Epstein-Barr Virus Infections/prevention & control; Hematopoietic Stem Cell Transplantation/adverse effects; Lymphoproliferative Disorders/therapy; Rituximab/administration & dosage; Viremia/prevention & control; Adolescent; Adult; Aged; Clinical Decision-Making/methods; Drug Administration Schedule; Epstein-Barr Virus Infections/epidemiology; Epstein-Barr Virus Infections/etiology; Female; Follow-Up Studies; Herpesvirus 4, Human/drug effects; Herpesvirus 4, Human/isolation & purification; Herpesvirus 4, Human/physiology; Humans; Lymphoproliferative Disorders/mortality; Male; Middle Aged; Models, Biological; Patient Selection; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Homologous/adverse effects; Treatment Outcome; Viral Load/drug effects; Viremia/epidemiology; Viremia/etiology; Virus Activation/drug effects; Young Adult

Key words

EpsteinBarr virus; allogeneic stem cell transplantation; rituximab

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viremia / Hematopoietic Stem Cell Transplantation / Epstein-Barr Virus Infections / Rituximab / Lymphoproliferative Disorders Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2019 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google